Medreich

Executive Summary

Medreich Limited is a well-established Indian contract development and manufacturing organization (CDMO) with over four decades of experience in small-molecule pharmaceutical formulations. Headquartered in Bengaluru, the company provides end-to-end services from proof-of-concept and formulation development to clinical and commercial GMP manufacturing, analytical testing, and packaging design. Its expertise spans multiple therapeutic areas including general medicine, oncology, cardiovascular, and central nervous system treatments. Medreich primarily serves regulated markets worldwide, leveraging its strong regulatory compliance and manufacturing capabilities to attract global clients. As a private company with 500-1000 employees, it operates at a commercial stage without disclosed funding or valuation, indicating a self-sustaining business model. Despite limited public information, Medreich's long track record and focus on high-quality CDMO services position it as a reliable partner for pharmaceutical companies seeking scalable manufacturing solutions.

Upcoming Catalysts (preview)

• TBDNew regulatory approvals from USFDA or EMA for manufacturing facilities60% success
• TBDMajor contract wins with global pharmaceutical companies50% success
• TBDExpansion of production capacity or new dosage form capabilities55% success